ESOPHAGEAL ADENOCARCINOMA
Clinical trials for ESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a tiny dose of radiation reboot cancer treatment?
Disease control Not yet recruitingThis study tests whether a single, low dose of radiation to all visible tumors can help immunotherapy work again in people with advanced esophageal cancer that stopped responding to standard treatment. About 32 adults will receive one round of low-dose radiation and then continue…
Matched conditions: ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Could a fungal drug stop esophageal cancer before it starts?
Prevention Not yet recruitingThis study tests whether adding the antifungal drug itraconazole to standard ablation therapy can prevent esophageal cancer in people with high-risk Barrett's esophagus. About 64 participants will receive either itraconazole or a placebo alongside their usual endoscopic ablation.…
Matched conditions: ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 15, 2026 18:57 UTC